Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) corresponding to Human LPP aa 1-100 (N terminal).
This product is a recombinant rabbit monoclonal antibody.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
Our Abpromise guarantee covers the use of ab126608 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/10000 - 1/50000. Detects a band of approximately 75 kDa (predicted molecular weight: 66 kDa).|
|IHC-P||1/250 - 1/500.|
|ICC/IF||1/100 - 1/250.|
ab126608 has not yet been referenced specifically in any publications.